* Kyverna Therapeutics press release [https://seekingalpha.com/pr/20198562-kyverna-therapeutics-provides-business-update-and-reports-second-quarter-2025-financial] (NASDAQ:KYTX [https://seekingalpha.com/symbol/KYTX]): Q2 GAAP EPS of -$0.97 beats by $0.07.
* Kyverna reported $211.7 million in cash, cash equivalents, and marketable securities as of June 30, 2025
MORE ON KYVERNA THERAPEUTICS
* Kyverna Therapeutics appoints Marc Grasso as CFO [https://seekingalpha.com/news/4463766-kyverna-therapeutics-appoints-marc-grasso-as-cfo]
* Seeking Alpha’s Quant Rating on Kyverna Therapeutics [https://seekingalpha.com/symbol/KYTX/ratings/quant-ratings]
* Historical earnings data for Kyverna Therapeutics [https://seekingalpha.com/symbol/KYTX/earnings]
* Financial information for Kyverna Therapeutics [https://seekingalpha.com/symbol/KYTX/income-statement]
Kyverna Therapeutics GAAP EPS of -$0.97 beats by $0.07
Published 2 months ago
Aug 12, 2025 at 9:13 PM
Positive
Auto